Development of thymocytes can be staged according to the levels of expression of the cell-surface markers CD4, CD8, CD44, CD25 and CD2. Thymocyte development is regulated by a complex signalling network [1], one component of which is the GTPase Rho. The bacterial enzyme C3 transferase from Clostridium botulinum selectively ADP-ribosylates Rho in its effector-binding domain and thereby abolishes its biological function [2, 3] . To explore the function of Rho in thymocyte development, we previously used the proximal promoter of the gene encoding the Src-family kinase p56lck to make transgenic mice that selectively express C3 transferase in the thymus [4-6]. In these mice, which lack Rho function from the earliest thymocyte stages, thymocyte numbers are reduced by approximately 50-to 100-fold. Here, we describe transgenic mice that express C3 transferase under the control of the locus control region (LCR) of the CD2 gene; this regulatory element drives expression at a later stage of thymocyte development than the lck proximal promoter [7] . In these mice, thymocyte numbers were also reduced by 50-to 100-fold, but unlike the lck-C3 mice, in which the reduction predominantly results from defects in cell survival of CD25 + thymocyte progenitors, the CD2-C3 transgenic mice had a pre-T-cell differentiation block at the CD25 + stage after rearrangement of the T-cell receptor (TCR) β β chains. Analysis of CD2-C3 mice demonstrated that Rho acts as an intracellular switch for TCRβ β selection, the critical thymic-differentiation checkpoint. These results show that Rho-mediated survival signals for CD25 + pre-T cells are generated by the extracellular signals that act on earlier thymocyte precursors and also that temporal cell-type-specific elimination of Rho can reveal different functions of this GTPase in vivo. 
Results and discussion
We generated transgenic mice that expressed C3 transferase under the control of the human CD2 promoter (see Figure 1 for stages of thymocyte development and kinetics of CD2-C3 and lck-C3 expression). Thymi from three independent lines of CD2-C3 transgenic mice were consistently smaller than those of littermate controls (Figure 2a ). Thymocyte numbers from 4-week-old CD2-C3 mice were reduced approximately 50-to 100-fold over those of normal littermate controls (Figure 2b ). Thymi from CD2-C3 mice almost exclusively contained CD4 -CD8 -double-negative (DN) cells (Figure 2c ). Calculations of absolute cell numbers showed that the levels of CD4 -CD8 -DN cells in CD2-C3 mice were within the normal range, but all further stages of thymocyte development were effectively absent. Loss of Rho function in CD2-C3 transgenic mice therefore blocked thymocyte differentiation at the CD4 -CD8 -DN stage. CD4 -CD8 -DN thymocytes from CD2-C3 mice contained a marked increase in the CD44 -CD25 + subpopulation compared with non-transgenic littermate controls ( Figure 2d ). CD25 levels on CD44 -CD25 + cells from CD2-C3 mice were elevated compared with CD25 levels on control cells (Figure 2e ). CD25 is normally downregulated upon expression of a pre-TCR complex on the thymocyte surface membrane. Failure of the pre-TCR complex either to be expressed or to signal correctly results in increased levels of CD25 expression [8] [9] [10] . Increased levels of CD25 are therefore consistent with a block in pre-TCR expression or function.
Differentiation of CD44 -CD25 + thymocytes depends on cells successfully rearranging their TCRβ loci and expressing a functional pre-TCR on their surface; failure of β-chain rearrangement results in a differentiation block.
We investigated whether rearranged β chains were present in CD25 + cells from CD2-C3 mice by intracellular staining with an antibody to a common β-chain epitope [11] . β-chain rearrangement is accompanied by a transition from small 'E' cells (β-chain-negative) to large blast-like 'L' cells (all of which express rearranged β subunits) [12] . CD25 + E and L cells were present in CD2-C3 mice. CD25 + L cells from CD2-C3 mice all expressed readily detectable levels of intracellular TCRβ subunits, although at slightly lower than normal levels (Figure 2f ).
The differentiation block in thymocytes that fail to express a pre-TCR complex can be overcome by expression of transgenes encoding mature, rearranged TCRαβ chains [13] . To determine whether TCR expression could induce the differentiation of thymocyte progenitors into CD4 + CD8 + (double-positive; DP) cells in CD2-C3 mice, these mice were crossed with transgenic mice expressing the HY-TCR, which recognises a male antigen-derived peptide in the context of a major histocompatibility (MHC) class I molecule. Male HY-TCR mice show massive deletion of CD4 + CD8 + thymocytes [14] , whereas in female HY-TCR mice, positive selection of CD8 + singlepositive (SP) thymocytes from CD4 + CD8 + DP thymocytes proceeds normally. Surface expression levels of HY-TCR were similar on CD4 -CD8 -DN thymocytes isolated from HY-TCR mice and CD2-C3/HY-TCR double-transgenic mice (Figure 2g ). Female CD2-C3/HY-TCR mice contained no CD4 + CD8 + DP cells (Figure 2h ). Thus, expression of a stable, mature TCR complex in CD2-C3 mice could not induce the differentiation of pre-T cells from the CD4 -CD8 -DN stage to the CD4 + CD8 + DP stage. These results do not preclude the possibility that Rho might regulate the surface expression and/or stability of a pre-TCR complex, but they do show that when there is stable TCR expression, TCR signalling requires endogenous Rho function to drive thymocyte differentiation at the pre-Tcell stage. Rho function is therefore required for signalling by the pre-TCR complex, thereby acting as an intracellular switch for the critical checkpoint of TCRβ selection.
Thymi from lck-C3 transgenic mice were small and hypocellular and had external morphology indistinguishable from that of CD2-C3 thymi (Figure 2a) . However, lck-C3 thymi showed a completely different pattern of thymocyte differentiation from that of CD2-C3 thymi (Figure 3a) : lck-C3 thymi contained CD4 -CD8 -DN, CD4 + CD8 + DP and CD4 + or CD8 + SP cells, whereas CD2-C3 thymi lacked DP and SP cells. Moreover, CD4 -CD8 -DN cells from lck-C3 thymi were not CD25 + and were mostly CD44 + CD25 - (Figure 3b ). In CD2-C3 mice, CD44 -CD25 + cells represented the predominant subpopulation of CD4 -CD8 -DN cells. The depletion of CD25 + thymocytes in lck-C3 transgenic mice is explained by massive apoptosis [4, 5] , detectable by staining with the fluorescent dye 7-amino-actinomycin D (7AAD), which detects apoptotic cells on the basis of increased cell membrane permeability. In contrast to lck-C3 mice, CD25 + cells from CD2-C3 mice did not show increased levels of apoptosis ( Figure 3c ).
The differences between these two strains of transgenic mice are striking: CD25 + thymocytes from CD2-C3 mice showed a differentiation block but had no problems with cell survival, whereas CD25 + thymocytes from lck-C3 mice were apoptotic, with the few surviving cells undergoing normal differentiation. Thus, insights gained into Rho function in CD25 + thymocytes are very different depending on whether lck-C3 transgenic mice or CD2-C3 transgenic mice are studied. It should be emphasised that four independent lines of lck-C3 transgenic mice have been generated with different copy numbers and all showed the same phenotype -survival defects but apparently normal thymocyte differentiation. Similarly, blocks to thymocyte differentiation but no survival defects were seen in three lines of CD2-C3 mice.
Expression of the C3 transferase transcript in CD2-C3 mice could be detected on day 12 of embryogenesis, whereas in lck-C3 mice it was detectable on day 11. Studies in adult mice confirmed expression of C3 transferase in CD44 + CD25 -cells from lck-C3 mice; the CD2-driven C3 transgene was expressed later, when CD25 + cells appeared (see Supplementary material published with this paper on the internet). Inhibition of Rho before the CD25 + stage, as in the lck-C3 mice, resulted in increased levels of cell death, but inhibition directly in 658 Current Biology, Vol 9 No 12
Figure 1
The stages of thymocyte development and the kinetics of lck and CD2 expression. Early T-cell progenitors are CD4 -CD8 -(double-negative; DN) and go through the CD44 + CD25 -, CD44 + CD25 + , CD44 -CD25 + and CD44 -CD25 -stages in order [15, 16] . Cells that successfully rearrange their T-cell receptor β-chain loci express a functional pre-T-cell receptor (pre-TCR), downregulate CD25 expression, proliferate rapidly and differentiate into CD4 + CD8 + double-positive (DP) cells [12, 17] . CD4 + CD8 + DP cells undergo TCR α-chain rearrangements and, upon expression of a functional TCRαβ, differentiate into mature CD4 + or CD8 + single-positive (SP) cells [18] . The lck proximal promoter is active from the CD44 + CD25 -stage until cells exit the thymus into the periphery; CD2 expression begins in the CD44 + CD25 + population, as cells start to rearrange their TCR β-chain loci. in pre-T cells in CD2-C3 mice reveals the essential role of Rho for pre-T-cell differentiation.
Supplementary material
Additional methodological details and a figure showing kinetics of transgene expression are published with this paper on the internet. 
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Supplementary materials and methods
Transgenic mice
A purified 11.2 kb KpnI-NotI fragment (2 ng/ml) containing the CD2-C3 transgene was injected into the pronuclei of day-1 F1 mouse zygotes (C57/BL6/J × CBA/J). Embryos were transferred into pseudopregnant F1 foster mice which gave birth to litters of 5-10 mice 20 days later. Stable lines were generated by backcrossing transgenecarrying founder mice with C57/BL6/J mice. Transgenic mice expressing the TCR that reacts with the male-specific HY antigen were kindly provided by H. von Boehmer [S1].
PCR
Transgene-carrying mice were identified by PCR with transgene-specific primers: VAh2 (5′-GTCCCAACCCAGCTTTCCCTG-3′) and C3NT (5′-CTGATTTGCTTAGTCCATAC-3′) or VAh4 (5′-GGGGA-CAATGAGTTTTCTGCTG-3′) and C3CT (5′-GGGCACAGCTAT-CAATCC-3′). Genomic DNA was purified from mouse ear punches and used as template for 30 cycles of PCR (57°C annealing, 72°C elongation, 95°C denaturation).
Reverse-transcriptase PCR (RT-PCR) from fetal thymi
Fetal thymic lobes (embryonic day [13] [14] [15] and total embryos (embryonic day 10-12) were dissolved in 500 µl RNazol (Cinna Scientific). Total RNA was extracted according to the manufacturer's instructions and subjected to DNase treatment. The reverse transcriptase (RT) reaction was performed using random hexamer primers, and the cDNA obtained was used as template for PCR reactions employing primers specific for HPRT (5′-CACAGGACTAGAACACCTGC-3′ and 5′ -GCTGGTGAAAAGGACCTCT-3′), p56lck (5′-GCCCATCCGGAATG-GCTCTG-3′ and 5′-CGCCACGAAGTTGAAGGG-3′) and C3 transferase (5′-GAGGGAACCCAGTCAGTCAGGAGC-3′ and 5′-CT-GATTTGCTTAGTCCATAC-3′). PCR reactions were performed in 20 mM ammonium sulphate, 75 mM Tris-HCl pH 9.0, 0.01% Tween 20, 1.2 mM MgCI 2 , 200 mM dNTP, 0.5 U Taq DNA polymerase, and 1 mM of each primer. DNA was amplified for 35 cycles at an annealing temperature of 57ºC. PCR products were separated in 2% agarose gels and stained with ethidium bromide.
Cell preparation
Thymi were obtained by dissection from 4-6-week-old mice. Tissue was disaggregated with fine forceps and forced through a fine mesh filter to obtain a single-cell suspension.
Flow cytometric analysis
Antibodies (Pharmingen) were obtained conjugated to either fluorescein isothiocyanate (FITC), phycoerythrin (PE) or biotin. Biotinylated antibodies were revealed using streptavidin-tricolor (Caltag). Thymocytes were stained for surface expression of the following markers using the antibodies given in brackets: CD8 (53-5.8), CD4 (RM4-5), CD25 (IL2Rαchain, 3C7), CD3ε (145-2C11), αβTCR (β-chain, H57-597), B220 (CD45R, RA3-6B2), CD44 (Pgp-1, IM7), CD2 (LFA-2, RM2-5), Mac-1 (CD11b, M1/70), Gr-1 (Ly-6G,RB6-8C5) and HY-TCR (T3.70). Cells were stained with saturating concentrations of antibody at 4°C for 20 min at 2 × 10 6 cells per sample in a 96-well V-bottomshaped microtitre plate in 100 µl PBS containing 1% bovine serum albumin. Cells were washed with this buffer between incubations and before analysis on a Calibur fluorescence-activated cell sorter (FACS; Becton Dickinson). Events were collected and stored ungated in list mode using CellQuest software. Live cells were gated according to their forward-scatter (FSC) and side-scatter (SSC) profiles and data were analysed using CellQuest software.
Apoptosis assay
Thymocytes were stained with a FITC-labelled monoclonal antibody against CD25 in RPMI medium supplemented with 10% FCS. After washing, cells were incubated with 7AAD (Calbiochem) for 20 min at 4°C in the dark. Cells were analysed by flow cytometry, with apoptotic cells being identified by 7AAD staining as described [S2]. 
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Figure S1
Temporal expression of C3 transferase as analysed by RT-PCR. RNA was prepared from total embryos (embryonic day 10-12) and thymic lobes (embryonic day [13] [14] [15] and was used as a template for cDNA synthesis. The presence of the C3 and hypoxanthine phosphoribosyltransferase (HPRT; control) transcripts was determined by PCR. 
